All Roll Calls
Yes: 446 • No: 29
TexasHB 463889th Legislature Regular SessionHouse
Relating to the Texas Pharmaceutical Initiative.
Sponsored By: Greg Bonnen, Lois Kolkhorst (Republican)
Signed by Governor
Education--Higher--Institutions & ProgramsGovernorHealth--GeneralRetirement Systems--State EmployeesRetirement Systems--TeachersState Agencies, Boards & CommissionsPHARMACEUTICAL INITIATIVE GOVERNING BOARD, TEXAS
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Texas drug initiative gets two more years
Beginning September 1, 2025, the law extends the Texas Pharmaceutical Initiative’s expiration date by two years. Its governing law now expires September 1, 2027, instead of September 1, 2025. This extension does not directly change household drug costs, benefits, or who qualifies.
Sponsors & Cosponsors
Sponsors
Greg Bonnen
House
Lois Kolkhorst
Republican • Senate
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
House vote • 5/29/2025
Record vote
Yes: 124 • No: 11
Senate vote • 5/27/2025
Record vote
Yes: 0 • No: 0
Senate vote • 5/27/2025
Record vote
Yes: 29 • No: 2
House vote • 5/7/2025
Record vote
Yes: 140 • No: 6
House vote • 5/6/2025
Record vote
Yes: 134 • No: 10
House vote • Unknown
Committee vote: Public Health
Yes: 11 • No: 0
Senate vote • Unknown
Committee vote: Health & Human Services
Yes: 8 • No: 0
Actions Timeline
Effective on 9/1/25
6/20/2025HouseSigned by the Governor
6/20/2025HouseSent to the Governor
6/1/2025HouseSigned in the Senate
6/1/2025SenateSigned in the House
5/31/2025HouseReported enrolled
5/30/2025HouseHouse concurs in Senate amendment(s)-reported
5/29/2025SenateText of Senate Amendment(s)
5/29/2025HouseStatement(s) of vote recorded in Journal
5/29/2025HouseRecord vote (RV#4038)
5/29/2025HouseHouse concurs in Senate amendment(s)
5/29/2025HouseSenate Amendments Analysis distributed
5/28/2025HouseSenate Amendments distributed
5/28/2025HouseSenate passage as amended reported
5/28/2025HouseRecord vote
5/27/2025SenatePassed
5/27/2025SenateRead 3rd time
5/27/2025SenateRecord vote
5/27/2025SenateThree day rule suspended
5/27/2025SenateVote recorded in Journal
5/27/2025SenatePassed to 3rd reading as amended
5/27/2025SenateVote recorded in Journal
5/27/2025SenateAmended
5/27/2025SenateAmendment(s) offered (FA1 Kolkhorst)
5/27/2025SenateRead 2nd time
5/27/2025Senate
Bill Text
Engrossed
Enrolled
House Committee Report
Introduced
Senate Committee Report
Related Bills
SB 2111, Relating to legal representation of indigent persons in this state and to proceedings before a magistrate including the appointment of counsel for an indigent defendant.
SB 1838, Relating to the appointment of attorneys ad litem and the compensation of certain attorneys ad litem in suits affecting the parent-child relationship filed by a governmental entity.
SB 3, Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.
SB 2878, Relating to the operation and administration of and practices and procedures related to proceedings in the judicial branch of state government, including court security, court documents and arrest warrants, document delivery, juvenile boards, constitutional amendment election challenges, mandatory expunction for certain persons, record retention, and youth diversion; increasing a criminal penalty; authorizing fees.
SB 646, Relating to repayment of certain mental health professional education loans.
HB 4325, Relating to civil liability for prohibited barratry.